Carbonic anhydrase inhibitors: Guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII)

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 30, Issue 4, 2015, Pages 586-591

  Scozzafava, Andrea ^a   Passaponti, Maurizio ^a   Supuran, Claudiu T ^a   Gülçin, Ilhami ^b,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ATATÜRK UNIVERSITY   (Turkey)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Carbonic anhydrases; catechol derivatives; enzyme inhibition; guaiacol derivatives; isoenzymes

Indexed keywords

3 METHOXY CATECHOL; 3 METHYL CATECHOL; 4 METHYLGUAIACOL; 4 PROPYLGUAIACOL; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; CATECHOL; CATECHOL DERIVATIVE; EUGENOL; GUAIACOL; ISOEUGENOL; SYRINGALDEHYDE; UNCLASSIFIED DRUG; VANILLIN; ISOENZYME;

ARTICLE; DRUG STRUCTURE; ENZYME INHIBITION; HYDROGEN BOND; PRIORITY JOURNAL; X RAY CRYSTALLOGRAPHY; ANTAGONISTS AND INHIBITORS; CHEMISTRY; HUMAN;

MAMMALIA; VERTEBRATA;

CARBONIC ANHYDRASE INHIBITORS; CATECHOLS; GUAIACOL; HUMANS; ISOENZYMES;

EID: 84937196797     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2014.956310     Document Type: Article

References (91)

1. Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Disc 2008;7:168-81.
2. Capasso C, Supuran CT. Sulfa and trimethoprim-like drugsantimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem 2014;29:379-87.
3. Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72.
4. Güney M, Coşkun A, Topal F, et al. Oxidation of cyanobenzocycloheptatrienes: synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives. Bioorg Med Chem 2014;22:3537-43.
5. Said HM, Hagemann C, Carta F, et al. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human Glioblastoma. Bioorg Med Chem 2013;21:3949-57.
6. Alterio V, Di Fiore A, D'Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421-68.
7. Monti SM, Supuran CT, De Simone G. Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013). Expert Opin Ther Pat 2013;23:737-49.
8. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74.
9. Rummer JL, McKenzie DJ, Innocenti A, et al. Root effect hemoglobin may have evolved to enhance general tissue oxygen delivery. Science 2013;340:1327-9.
10. Nishimori I, Vullo D, Minakuchi T, et al. Sulfonamide inhibition studies of two b-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Bioorg Med Chem 2014;22:2939-46.
11. Çetinkaya Y, Göçer H, Gülçin I, Menzek A. Synthesis and carbonic anhydrase isoenzymes inhibitory effects of brominated diphenylmethanone and its derivatives. Arch Pharm 2014;347:354-9.
12. Smith KS, Jakubzick C, Whittam TS, Ferry JG. Carbonic anhydrase is an ancient enzyme widespread in prokaryotes. Proc Natl Acad Sci USA 1999;96:15184-9.
13. De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793-810.
14. Akincioglu A, Topal M, Gülçin I, Göksu S. Novel sulfamides and sulfonamides incorporating tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors. Arch Pharm 2014;347:68-76.
15. Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199-229.
16. Göçer H, Gülçin I. Caffeic acid phenethyl ester (CAPE): a potent carbonic anhydrase isoenzymes inhibitor. Int J Acad Res 2013;5: 150-5.
17. Durdagi S, Scozzafava G, Vullo D, et al. Inhibition of mammalian carbonic anhydrases I-XIV with grayanotoxin III: solution and in silico studies. J Enzyme Inhib Med Chem 2014;29:469-75.
18. Bilginer S, Unluer E, Gul HI, et al. Carbonic anhydrase inhibitors. Phenols incorporating 2-or 3-pyridyl-ethenylcarbonyl and tertiary amine moieties strongly inhibit Saccharomyces cerevisiae b-carbonic anhydrase. J Enzyme Inhib Med Chem 2014;29:495-9.
19. Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146-89.
20. Sharma A, Tiwari M, Supuran CT. Novel coumarins and benzocoumarins acting as isoform-selective inhibitors against the tumor-associated carbonic anhydrase IX. J Enzyme Inhib Med Chem 2014;29:292-6.
21. Pan J, Lau J, Mesak F, et al. Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography. J Enzyme Inhib Med Chem 2014;29:249-55.
22. Joseph P, Turtaut F, Ouahrani-Bettache S, et al. Cloning, Characterization, and inhibition studies of a b-carbonic anhydrase from Brucella suis. J Med Chem 2010;53:2277-85.
23. Burghout P, Vullo D, Scozzafava A, et al. Inhibition of the b-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: toward innovative drug design of antiinfectives? Bioorg Med Chem 2011;19:243-8.
24. Aksu K, Nar M, Tanç M, et al. The synthesis of sulfamide analogues of dopamine related compounds and their carbonic anhydrase inhibitory properties. Bioorg Med Chem 2013;21:2925-31.
25. Topal M, Gülçin I. Rosmarinic acid: a potent carbonic anhydrase isoenzymes inhibitor. Turk J Chem 2014;38:894-902.
26. Çetinkaya Y, Göçer H, Göksu S, Gülçin I. Synthesis and carbonic anhydrase isoenzymes inhibitory effects of novel benzylamine derivatives. J Enzyme Inhib Med Chem 2014;29:168-74.
27. Robbins RJ. Phenolic acids in foods: an overview of analytical methodology. J Agric Food Chem 2003;51:2866-87.
28. Gülçin I. Antioxidant activity of eugenol - a structure and activity relationship study. J Med Food 2011;14:975-85.
29. Gülçin I. Antioxidant activity of food constituents-an overview. Arch Toxicol 2012;86:345-96.
30. Gülçin I, Beydemir S. Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors. Mini Rev Med Chem 2013;13: 408-30.
31. Lauraguaisa A, Coeur-Tourneur C, Cassez A, et al. Atmospheric reactivity of hydroxyl radicals with guaiacol (2-methoxyphenol), a biomass burning emitted compound: secondary organic aerosol formation and gas-phase oxidation products. Atmos Environ 2014; 86:155-63.
32. Mohan D, Pittman CU, Steele PH. Pyrolysis of wood/biomass for bio-oil: a critical review. Energy Fuels 2006;20:848-89.
33. Elliott DC, Hart TR. Catalytic hydroprocessing of chemical models for bio-oil. Energy Fuels 2009;23:631-7.
34. Chang SS, Kang DH. Alicyclobacillus spp. in the fruit juice industry: history, characteristics, and current isolation/detection procedures. Crit Rev Microbiol 2004;30:55-74.
35. Bui VN, Toussaint G, Laurenti D, et al. Co-processing of pyrolisis bio oils and gas oil for new generation of bio-fuels: hydrodeoxygenation of guaiäcol and SRGO mixed feed. Catal Today 2009;143: 172-8.
36. Gutierrez A, Kaila RK, Honkela ML, et al. Hydrodeoxygenation of guaiacol on noble metal catalysts. Catal Today 2009;147:239-46.
37. Bykova MV, Ermakov DY, Kaichev VV, et al. Ni-based sol-gel catalysts as promising systems for crude bio-oil upgrading: guaiacol hydrodeoxygenation study. Appl Catal B 2012;113-114:296-307.
38. Nava B, Pawelec P, Castano MC, et al. Upgrading of bio-liquids on different mesoporous silica-supported CoMo catalysts. Appl Catal B 2009;92:154-67.
39. He W, Li Y, Si H, et al. Molecular modeling and spectroscopic studies on the binding of guaiacol to human serum albumin. J Photochem Photobiol A Chem 2006;182:158-67.
40. Bolton JL, Pisha E, Li S, et al. The reactivity of o-quinones which do not isomerize to quinone methods correlates with alkylcatecholinduced toxicity in human melanoma cells Chem Biol Interact 1997; 106:133-48.
41. Shirai K. Screening of microorganisms for catechol production from benzene Agric Biol Chem 1986;50:2875-80.
42. Dignum MJW, Kerler J, Verpoorte R. Vanilla production: technological, chemical, and biosynthetic aspects. Food Rev Int 2001;17: 119-20.
43. Held M, Schmid A, Kohler HPE, et al. An integrated process for the production of toxic catechols from toxic phenols based on a designer biocatalyst. Biotechnol Bioeng 1999;62:641-8.
44. Kauffman ME, Keener WK, Clingenpeel SR, et al. Use of 3-hydroxyphenylacetylene for activity-dependent, fluorescent labeling of bacteria that degrade toluene via 3-methylcatechol. J Microbiol Meth 2003;55:801-5.
45. Husken LE, Oomes M, Schroen K, et al. Membrane-facilitated bioproduction of 3-methylcatechol in an octanol/water two-phase system. J Biotechnol 2002;96:281-9.
46. Callizot N, Warter JM, Poindron P. Pyridoxine-induced neuropathy in rats: a sensory neuropathy that responds to 4-methylcatechol. Neurobiol Dis 2001;8:626-35.
47. Liu C, Zhang Y, Huang X. Study of guaiacol pyrolysis mechanism based on density function theory. Fuel Proces Technol 2014;123: 159-65.
48. Öztürk Sarikaya SB, Gülçin I, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids. Chem Biol Drug Des 2010;75:515-20.
49. Öztürk Sarikaya SB, Topal F, Şentürk M, et al. In vitro inhibition of a-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011;21:4259-62.
50. Innocenti A, Gülçin I, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Antioxidant polyphenol natural products effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett 2010;20:5050-3.
51. Innocenti A, Ozturk Sarikaya SB, Gulcin I, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem 2010;18:2159-64.
52. Gülçin I, Alici HA, Cesur M. Determination of in vitro antioxidant and radical scavenging activities of propofol. Chem Pharm Bull 2005;53:281-5.
53. Gülçin I, Daştan A. Synthesis of dimeric phenol derivatives and determination of in vitro antioxidant and radical scavenging activities. J Enzyme Inhib Med Chem 2007;22:685-95.
54. Gülçin I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 2006;217:213-20.
55. Gülçin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 2006;78:803-11.
56. Gülçin I. Comparison of in vitro antioxidant and antiradical activities of L-tyrosine and L-Dopa. Amino Acids 2007;32:431-8.
57. Gülçin I. Antioxidant activity of L-adrenaline: an activity-structure insight. Chem Biol Interact 2009;179:71-80.
58. Gülçin I. Antioxidant properties of resveratrol: a structure-activity insight. Innov Food Sci Emerg 2010;11:210-18.
59. Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides. Curr Pharm Des 2008;14: 641-8.
60. Ilkimen H, Yenikaya C, Sari M, et al. Synthesis and characterization of a proton transfer salt between 2,6-pyridinedicarboxylic acid and 2-aminobenzothiazole, and its complexes and their inhibition studies on carbonic anhydrase isoenzymes. J Enzyme Inhib Med Chem 2014;29:353-61.
61. Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Pat 2006;16:1627-64.
62. Innocenti A, Vullo D, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). Bioorg Med Chem Lett 2008;18:1583-7.
63. Steele RM, Batugo MR, Benedini F, et al. Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. Bioorg Med Chem Lett 2009;19:6565-70.
64. Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233-8.
65. Ahlskog JKJ, Dumelin CE, Trüssel S, et al. In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives. Bioorg Med Chem Lett 2009;19:4851-6.
66. Dubois L, Lieuwes NG, Maresca A, et al. Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model. Radiother Oncol 2009;92:423-8.
67. Nair SK, Ludwig PA, Christianson DW. Two-site binding of phenol in the active side of human carbonic anhydrase II: Structural implications for substrate association. J Am Chem Soc 1994;116: 3659-60.
68. Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057-62.
69. Davis RA, Innocenti A, Poulsen SA, Supuran CT. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library. Bioorg Med Chem 2010;18:14-18.
70. Senturk M, Gulcin I, Dastan A, et al. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009;17:3207-11.
71. Akbaba Y, Akincioglu A, Göçer H, et al. Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins. J Enzyme Inhib Med Chem 2014;29: 35-42.
72. Akincioglu A, Akbaba Y, Goçer H, et al. Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors. Bioorg Med Chem 2013;21:1379-85.
73. Nar M, Çetinkaya Y, Gülçin I, Menzek A. (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. J Enzyme Inhib Med Chem 2013;28:402-6.
74. Barclay LRC, Vinqvist MR, Mukai K, et al. Chain-breaking phenolic antioxidants: steric and electronic effects in polyalkylchromanols, tocopherol analogs, hydroquinones, and superior antioxidants of the polyalkylbenzochromanol and naphthofuran class. J Org Chem 1993;58:7416-20.
75. Tomiyama S, Sakai S, Nishiyama T, Yamada F. Factors influencing the antioxidant activities of phenols by an ab initio study. Bull Chem Soc Jpn 1993;66:299-304.
76. Sethi KK, Verma SM, Tanç M, et al. Carbonic anhydrase inhibitors: synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety. Bioorg Med Chem 2013;21:5168-74.
77. Winum JY, Maresca A, Carta F, et al. Polypharmacology of sulfonamides: pazopanib, a multitargeted receptor tyrosine kinase inhibitor in clinical use, potently inhibits several mammalian carbonic anhydrases. Chem Commun 2012;48:8177-9.
78. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 2000;10:575-600.
79. Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Fut Med Chem 2011;3:1165-80.
80. Chohan ZH, Supuran CT, Scozzafava A. Metal binding and antibacterial activity of ciprofloxacin complexes. J Enzyme Inhib Med Chem 2005;20:303-7.
81. Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74.
82. Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-50.
83. Ghorab MM, Alsaid MS, Ceruso M, et al. Carbonic anhydrase inhibitors: synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Bioorg Med Chem 2014;22: 3684-95.
84. Lou Y, McDonald PC, Oloumi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 2011;71:3364-76.
85. Zo1nowska B, S1awinskia J, Pogorzelska A, et al. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N0-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl) guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Eur J Med Chem 2014;71:135-47.
86. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol Med 1996;20:933-56.
87. Sroka Z, Cisowski W. Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem Toxicol 2003;41:753-8.
88. Göçer H, Çetinkaya Y, Göksu S, et al. Carbonic anhydrase and acetylcholine esterase inhibitory effects of carbamates and sulfamoylcarbamates. J Enzyme Inhib Med Chem. (in press) doi:10.3109/ 14756366.2014.928704.
89. Arabaci B, Gülçin I, Alwasel S. Capsaicin: a potent inhibitor of carbonic anhydrase isoenzymes. Molecules 2014;19:10103-14.
90. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561-73.
91. Şentürk M, Gülçin I, Beydemir Ş, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Des 2011;77:494-9.